185 related articles for article (PubMed ID: 15846775)
21. Cytogenetic characterization of seven human cancer cell lines by combining G- and R-banding, M-FISH, CGH and chromosome- and locus-specific FISH.
Cottier M; Tchirkov A; Perissel B; Giollant M; Campos L; Vago P
Int J Mol Med; 2004 Oct; 14(4):483-95. PubMed ID: 15375617
[TBL] [Abstract][Full Text] [Related]
22. Molecular cytogenetic characterization and diagnostics of bladder cancer.
Houskova L; Zemanova Z; Babjuk M; Melichercikova J; Pesl M; Michalova K
Neoplasma; 2007; 54(6):511-6. PubMed ID: 17949235
[TBL] [Abstract][Full Text] [Related]
23. Multiple recurrent chromosomal breakpoints in mantle cell lymphoma revealed by a combination of molecular cytogenetic techniques.
Salaverria I; Espinet B; Carrió A; Costa D; Astier L; Slotta-Huspenina J; Quintanilla-Martinez L; Fend F; Solé F; Colomer D; Serrano S; Miró R; Beà S; Campo E
Genes Chromosomes Cancer; 2008 Dec; 47(12):1086-97. PubMed ID: 18709664
[TBL] [Abstract][Full Text] [Related]
24. Spectral karyotype (SKY) analysis of human prostate carcinoma cell lines.
van Bokhoven A; Caires A; Maria MD; Schulte AP; Lucia MS; Nordeen SK; Miller GJ; Varella-Garcia M
Prostate; 2003 Nov; 57(3):226-44. PubMed ID: 14518030
[TBL] [Abstract][Full Text] [Related]
25. Fluorescence in situ hybridization detects frequent chromosome 9 deletions and aneuploidy in histologically normal urothelium of bladder cancer patients.
Obermann EC; Meyer S; Hellge D; Zaak D; Filbeck T; Stoehr R; Hofstaedter F; Hartmann A; Knuechel R
Oncol Rep; 2004 Apr; 11(4):745-51. PubMed ID: 15010867
[TBL] [Abstract][Full Text] [Related]
26. Correlating breakage-fusion-bridge events with the overall chromosomal instability and in vitro karyotype evolution in prostate cancer.
Vukovic B; Beheshti B; Park P; Lim G; Bayani J; Zielenska M; Squire JA
Cytogenet Genome Res; 2007; 116(1-2):1-11. PubMed ID: 17268171
[TBL] [Abstract][Full Text] [Related]
27. Novel recurrent structural chromosomal aberrations in primary bladder cancer.
Panani AD; Ferti AD; Raptis SA; Roussos C
Anticancer Res; 2004; 24(5A):2967-74. PubMed ID: 15517903
[TBL] [Abstract][Full Text] [Related]
28. Molecular cytogenetic analysis of oral squamous cell carcinomas by comparative genomic hybridization, spectral karyotyping, and fluorescence in situ hybridization.
Uchida K; Oga A; Okafuji M; Mihara M; Kawauchi S; Furuya T; Chochi Y; Ueyama Y; Sasaki K
Cancer Genet Cytogenet; 2006 Jun; 167(2):109-16. PubMed ID: 16737909
[TBL] [Abstract][Full Text] [Related]
29. [From "monocolor" karyotype to "multicolor" karyotype: applications of M-Fish in hematology and oncology].
Jaffray JY; Giollant M; Perissel B; Vago P
Bull Cancer; 2002 Feb; 89(2):174-80. PubMed ID: 11888857
[TBL] [Abstract][Full Text] [Related]
30. Chromosome analysis of esophageal squamous cell carcinoma cell line KYSE 410-4 by repetitive multicolor fluorescence in situ hybridization.
Yang Y; Chu J; Wu Y; Luo M; Xu X; Han Y; Cai Y; Zhan Q; Wang M
J Genet Genomics; 2008 Jan; 35(1):11-6. PubMed ID: 18222404
[TBL] [Abstract][Full Text] [Related]
31. Loss of heterozygosity analysis and DNA copy number measurement on 8p in bladder cancer reveals two mechanisms of allelic loss.
Adams J; Williams SV; Aveyard JS; Knowles MA
Cancer Res; 2005 Jan; 65(1):66-75. PubMed ID: 15665280
[TBL] [Abstract][Full Text] [Related]
32. The genetics of bladder cancer: a cytogeneticist's perspective.
Wolff DJ
Cytogenet Genome Res; 2007; 118(2-4):177-81. PubMed ID: 18000368
[TBL] [Abstract][Full Text] [Related]
33. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.
Simonetti S; Russo R; Ciancia G; Altieri V; De Rosa G; Insabato L
Int J Surg Pathol; 2009 Jun; 17(3):198-205. PubMed ID: 19443884
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive conventional and molecular cytogenetic characterization of B-CPAP, a human papillary thyroid carcinoma-derived cell line.
Dettori T; Frau DV; Garcia JL; Pierantoni G; Lee C; Hernandez JM; Fusco A; Morton CC; Vanni R
Cancer Genet Cytogenet; 2004 Jun; 151(2):171-7. PubMed ID: 15172756
[TBL] [Abstract][Full Text] [Related]
35. Integrated genomic and transcriptional analysis of the in vitro evolution of telomerase-immortalized urothelial cells (TERT-NHUC).
Chapman EJ; Williams SV; Platt FM; Hurst CD; Chambers P; Roberts P; Knowles MA
Genes Chromosomes Cancer; 2009 Aug; 48(8):694-710. PubMed ID: 19405089
[TBL] [Abstract][Full Text] [Related]
36. Interphase cytogenetic studies of bladder cancer.
Wang MR; Perissel B; Taillandier J; Malet P
Bull Cancer; 1994 Dec; 81(12):1060-6. PubMed ID: 7742594
[TBL] [Abstract][Full Text] [Related]
37. Y chromosome loss and other genomic alterations in hepatocellular carcinoma cell lines analyzed by CGH and CGH array.
Park SJ; Jeong SY; Kim HJ
Cancer Genet Cytogenet; 2006 Apr; 166(1):56-64. PubMed ID: 16616112
[TBL] [Abstract][Full Text] [Related]
38. Genomic imbalances in Schistosoma-associated and non-Schistosoma-associated bladder carcinoma. An array comparative genomic hybridization analysis.
Armengol G; Eissa S; Lozano JJ; Shoman S; Sumoy L; Caballín MR; Knuutila S
Cancer Genet Cytogenet; 2007 Aug; 177(1):16-9. PubMed ID: 17693186
[TBL] [Abstract][Full Text] [Related]
39. Comparative study of renal cell carcinoma by CGH, multicolor-FISH and conventional cytogenic banding analysis.
Sanjmyatav J; Schubert J; Junker K
Oncol Rep; 2005 Nov; 14(5):1183-7. PubMed ID: 16211283
[TBL] [Abstract][Full Text] [Related]
40. Identification of chromosome aberrations in esophageal cancer cell line KYSE180 by multicolor fluorescence in situ hybridization.
Wu YP; Yang YL; Yang GZ; Wang XY; Luo ML; Zhang Y; Feng YB; Xu X; Han YL; Cai Y; Zhan QM; Wu M; Dong JT; Wang MR
Cancer Genet Cytogenet; 2006 Oct; 170(2):102-7. PubMed ID: 17011979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
